phenformin has been researched along with gnetin h in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, AK; Balachandran, P; Claudio, PP; De Carlo, F; Eastham, L; Ibrahim, MA; Mouton, AJ; Pasco, DS; Penfornis, P; Singh, S; Tripathi, SK | 1 |
1 other study(ies) available for phenformin and gnetin h
| Article | Year |
|---|---|
The Oligostilbene Gnetin H Is a Novel Glycolysis Inhibitor That Regulates Thioredoxin Interacting Protein Expression and Synergizes with OXPHOS Inhibitor in Cancer Cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Glioblastoma; Glucose; Glycolysis; Humans; Phenformin; Thioredoxins | 2023 |